Page 42 - Sanket Koul

NHM helped increase central govt's spending on healthcare: CSEP-CPR study

Researchers add that this was largely due to the launch and subsequent expansion of spending on NHM in the first eight years

Looking to add around 1,000 beds by early FY26: Max Healthcare CMD Soi

Soi gives an overview of the company's performance in FY24 and its expansion plans for FY25

State regulators asked to withdraw marketing of cancer drug Olaparib

Manufacturer AstraZeneca Pharma India says its study shows drug may have detrimental effect

Medical device bodies welcome CDSCO order on self-reporting adverse effects

The drug regulator stated that medical device manufacturers need to take appropriate action for timely reporting of adverse events related to medical devices to MvPI

KKR acquires minority stake in Healthcare BPO firm Infinx for Rs 1,250 cr

Founded in 2012, Infinx is a provider of innovative, data-driven revenue cycle management solutions for the healthcare sector, with a particular focus on the US market

ICMR distances itself from BHU study on Covaxin, calls it 'poorly designed'

Bharat Biotech had then rebuked the BHU study, saying that its indigenously developed Covid vaccine Covaxin has shown an 'excellent safety track record' in various studies

Vulnerable population: Rising heat on public health infrastructure

Heat preparedness Measures for health care sector

Medical device companies get a three-month extension for licences

The step comes after several medical device associations and stakeholders had sent representations to the drug regulator, asking for an extension to adhere to the new licensing regulations

Medanta Hospitals Q4 results: Net profit up 25%, revenue rises 14.3%

The hospital operator's revenue from operations rose to Rs 808.6 crore in Q4 FY24, a 14.3 per cent rise from Rs 707 crore in Q4 FY23

Indian pharma firms supplied 47% of all generic prescriptions in US in 2022

Indian pharmaceutical companies also accounted for a lower but important share of biosimilar production, manufacturing 15 per cent of biosimilar volume used by US patients in 2022

Diabetes to infections: NPPA slashes retail prices of 41 essential drugs

Prices of essential drugs such as dapagliflozin metformin hydrochloride, used for lowering blood glucose levels by decreasing glucose production in the liver, have been fixed at Rs 16 per tablet

Mankind Pharma open to acquisitions; board okays Rs 7,500 cr fundraise

The drug maker was reportedly interested in buying private equity (PE) firm Advent International's stake in Mumbai-based biopharma firm Bharat Serums and Vaccines (BSV)

India set to cross 1800 MW in data centre capacity by 2026: CBRE report

Report adds that India has highest DC capacity among major APAC countries, likely to add another 850 MW in next 2 years

Mankind Pharma Q4 results: Net profit up by 62%, revenue rises by 18.9%

Mankind's revenue from operations rose to Rs 2,441 crore in Q4 FY24, an 18.9 per cent Y-o-Y rise from Rs 2,052 crore reported in Q4 FY23

PE firm ChrysCapital to invest up to Rs 830 crore in Centre For Sight

"This investment will support CFS's ability to further scale and serve the growing demand for eye care in India both across Tier-I and Tier-II cities," the statement added

Indian senior living market has potential to touch $12 bn by 2030: Report

Rise in median age and ageing population to fuel increase in demand for senior housing

AstraZeneca to withdraw Covid-19 vaccine Vaxzevria globally on weak demand

AstraZeneca will start the withdrawal of marketing authorisation for the vaccine in Europe

Abbott India Q4 results: Profit rises 24% to Rs 287 cr, revenue up 7%

The drugmaker's revenue from operations increased to Rs 1,439 crore, a 7 per cent increase from the Rs 1,343 crore recorded in Q4 FY23

Omron's India arm, AliveCor to market AI-based portable ECG in India

While stroke risk is 3.4 times higher with hypertension, it becomes nearly five times higher with Afib, which means that people who frequently experience Afib could face a stroke shortly

Birla Fertility acquires Kerala-based AMRC IVF to foray into South India

According to industry sources, the deal is valued at below Rs 100 crore, and the transaction will be financed through internal accruals